Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Vas-01 by VasGene Therapeutics for Metastatic Transitional (Urothelial) Tract Cancer: Likelihood of Approval
Vas-01 is under clinical development by VasGene Therapeutics and currently in Phase II for Metastatic Transitional (Urothelial) Tract Cancer. According...
Data Insights
Vas-01 by VasGene Therapeutics for Prostate Cancer: Likelihood of Approval
Vas-01 is under clinical development by VasGene Therapeutics and currently in Phase II for Prostate Cancer. According to GlobalData, Phase...